Background. Oxidative stress and low antioxidant status are implicated in the pathogenesis of inflammatory and autoimmune diseases. Pemphigus vulgaris (PV) is an extremely severe autoimmune bullous dermatosis characterized by intraepithelial bullae on the skin and mucosa, and its antioxidant status is not fully understood. Aim. To assess correlations between PV and serum antioxidant levels of bilirubin, uric acid (UA) and albumin. Methods. We enrolled 116 patients newly diagnosed with PV who were admitted to the First Affiliated Hospital of Guangxi Medical University (Guangxi, China), and 108 healthy controls (HCs). Clinical characteristics and laboratory parameters of patients were retrospectively analysed. Results. Our survey shows that compared with the HC groups, serum levels of bilirubin [total bilirubin (Tbil), direct bilirubin (Dbil) and indirect bilirubin (Ibil)], UA and albumin were significantly lower in patients with PV, regardless of sex. In all groups, serum Tbil, Dbil, Ibil, UA and albumin levels were lower for women than for men. Severity of pemphigus was slightly negatively associated with Tbil, Dbil and Ibil, but was not associated with UA or albumin. Moreover, when the data were adjusted for the covariances of age and sex separately, Tbil, Dbil, Ibil, UA and albumin were all relevant to PV.
Introduction
Oxidative stress is a pathological state due to generation of excessive amounts of reactive oxygen species to levels greater than the capacity of the body's antioxidant processes, which can lead to cell apoptosis and accumulation of apoptotic remnants, promote the formation of autoantibodies, and trigger an autoimmune cascade reaction. [1] [2] [3] Currently, it is believed that the occurrence and development of autoimmune diseases is a multifactorial and multistep process, and that oxidative stress is a triggering factor that plays a role not only in the pathogenesis of autoimmune disease, but also in the deterioration of such disease. 4 To maintain an appropriate cellular redox balance, enzymatic and nonenzymatic antioxidant defence systems should control the production of excess ROS by scavenging or decreasing ROS levels.
Bilirubin has long been regarded as a cytotoxic metabolite of iron porphyrin, but in recent years, it has been found to have a variety of biological actions, such as anti-inflammatory, antioxidant, immunomodulatory, cytoprotective and neuroprotective activities. 5, 6 Furthermore, the antioxidative capacity of bilirubin is stronger than that of a-tocopherol (vitamin E), catalase and superoxide dismutase. 5 Uric acid (UA), the end product of the common pathway of purine metabolism, is a natural antioxidant with metal-chelating properties, and reacts with nitrogen radicals and superoxide. 7 Moreover, some studies have confirmed that serum albumin is a major antioxidant in extracellular fluids and possesses antioxidant properties. 8 Consequently, not only can serum bilirubin, UA and albumin reduce global oxidative stress, but they may also reflect the antioxidant status in the body.
There is overwhelming evidence that oxidative stress is intimately involved in the development and progression of autoimmune skin disease, such as systemic lupus erythematosus (SLE), 9 psoriasis 10 and Behc ßet disease (BD). 11 Pemphigus vulgaris (PV) is an extremely severe autoimmune bullous dermatosis mediated by autoantibodies directed against transmembrane adhesion glycoproteins [desmoglein (Dsg)1 and Dsg3)] and characterized by intraepithelial bullae on skin and mucosa. 12 However, the association between antioxidant status and PV is still unclear. Hence, the aim of this study was to evaluate the correlation between PV and serum antioxidant levels of bilirubin, UA and albumin by performing a hospital-based study.
Methods
The study was conducted in accordance with the Declaration of Helsinki and approved by the institutional review board of the First Affiliated Hospital of Guangxi Medical University.
Participants
We assessed all patients newly diagnosed with PV who were admitted to the First Affiliated Hospital of Guangxi Medical University (Guangxi, China) for inclusion in the study. Exclusion criteria were history/ presence of various conditions, such as renal or hepatic failure, biliary disease (such as gallstones, cholecystitis or gallbladder polyps), cardiovascular disease, diabetes, acute or chronic infection, cancer, mental illness or other systemic-associated autoimmune disease; smoking or alcohol consumption; and use of antioxidant drugs, diuretics, vitamins, hormone replacement therapy.
We enrolled 116 patients into the study group, while the control group was comprised of 120 ageand sex-matched healthy controls (HCs) who had received a routine medical checkup in the hospital. Clinical characteristics and laboratory parameters of patients were retrieved from the centre's database. Diagnosis of PV was based on clinical, histological (suprabasal cleft and acantholysis) and immunological (intercellular deposits of IgG and/or C3) criteria for the disease. Demographic and clinical characteristics of patients and HC groups are presented in Table 1 .
Data collected included: age, sex, total bilirubin (Tbil), direct bilirubin (Dbil), indirect bilirubin (Ibil), UA and albumin levels. Serum concentrations of Tbil, Dbil, Ibil, UA and albumin were measured using an automatic biochemical analyser (Model 7600-120; Hitachi High Technologies, Tokyo, Japan). Disease activity was measured by Pemphigus Area and Activity Score (PAAS). 13 
Statistical analysis
Data were analysed using SPSS statistical software (17.0; SPSS, Chicago, IL, USA), and results expressed as mean AE SD. All statistical tests were two-sided, and statistical significance was set at P < 0.05. Concentrations of bilirubin, UA and albumin in the PV and HC groups were compared using one-way ANCOVA, with age as covariant. Different subgroups of patients with Table 1 Baseline demographics and clinical characteristics of patients with pemphigus vulgaris and healthy controls.
Characteristic
Patients with PV (n = 116) HCs (n = 120) P PV were also compared using ANCOVA to analyse whether age affects levels of serum bilirubin, UA and albumin. Furthermore, potential associations between disease severity and serum levels of bilirubin, UA and albumin were assessed with Spearman correlation test. Relevant factors related to PV, including Tbil, Dbil, Ibil, UA and albumin, which were separately assessed with age and sex as covariants, were determined by logistic regression analysis.
Results
Compared with HCs, patients with PV had significantly lower serum levels of Tbil, Dbil and Ibil (P < 0.001, P < 0.001 and P < 0.001, respectively) ( Table 2 , Fig. 1a-c) . Each group was further divided into subgroups to assess influence of sex; again, compared with HCs, patients with PV had lower Tbil, Dbil, and Ibil levels, irrespective of sex ( Table 2 , Fig. 1a-c) .
There was also a statistically significant difference in serum UA (mean AE SD), which was 210.58 AE 66.12 lmol/L and 292.46 AE 77.21 lmol/L in the PV and HC groups, respectively (P < 0.001) ( Table 2 , Fig. 1d ). This remained significant after adjusting for sex (male subgroup 238.31 AE 66.03 lmol/L in patients with PV vs. 350.03 AE 54.95 lmol/L in HCs, P < 0.001; female subgroup 181.88 AE 53.05 vs. 234.88 AE 47.55 lmol/L, respectively, P < 0.001) ( Table 2 , Fig. 1d) .
Similarly, serum levels of albumin were also lower in the PV than in the HC group (P < 0.001) ( Table 2 , Fig. 1e ). Again, there was no sex difference, with serum albumin levels being lower in both the male and female PV subgroups compared with HCs (Table 2 , Fig. 1e) .
However, when we compared serum bilirubin, UA and albumin levels for men and women in all groups, were found that mean serum levels of Tbil, Dbil, Ibil, UA and albumin were significantly lower in men than in women (Table 2 ). In patients with PV, there were no associations between severity of PV and levels of serum UA (r = À0.01, P = 0.73) or albumin (r = À0.17, P = 0.34). However, severity of pemphigus was slightly negatively associated with Tbil (r = À0.25, P < 0.01), Dbil (r = À0.194, P < 0.04) and Ibil (r = À0.22, P < 0.02).
Furthermore, to illuminate the associations between serum bilirubin, UA and albumin levels and PV, we use logistic regression to analyse OR for Tbil, Dbil, Ibil, UA and albumin in patients with PV. After adjustment for age and sex, the following serum levels were all found to be relevant factors for PV by multivariate logistic regression: Tbil (OR = 0.38, 95% CI 0.29-0.49, P < 0.001) (Table 3) , Dbil (OR = 0.225, 95% CI 0.151, 0.335, P < 0.001), Ibil (OR = 0.66, 95% CI 0.57-0.76, P < 0.001), UA (OR = 0.97, 95% CI 0.97-0.98, P < 0.001) and albumin (OR = 0.35, 95% CI 0.25-0.50, P < 0.001, respectively) ( Table 3 ).
Discussion
Our study revealed that serum levels of Tbil, Dbil, Ibil, UA and albumin in patients with PV were significantly lower compared with those in HCs. Furthermore, similar results were obtained when male and female subgroups were investigated separately. To our knowledge, there have been no reports to date that antioxidant status of bilirubin, UA and albumin is associated with PV regardless of sex and age.
PV is an extremely severe autoimmune bullous dermatosis, which results from autoantibodies directed against the transmembrane adhesion glycoproteins Dsg1 and Dsg3, and characterized by intraepithelial bullae on the skin and mucosa. 12 As oxidative stress is intimately involved in the development and progression of autoimmune skin disease, including SLE, 9 psoriasis 10 and BD, 11 it seems likely that PV is one of the autoimmune skin diseases whose pathogenesis may be associated with low antioxidant levels.
ROS cause damage to cells and tissues through a variety of mechanisms, including directly attacking cellular lipids, proteins and DNA, and indirectly upregulating expression of apoptosis-related genes. 14 The main products of lipid oxidation include malondialdehyde (MDA), lipid hydroperoxide (LOOH), conjugated diene and F2-isoprostanes, and the main sign of protein oxidation is reduction in the number of carbonyl (-CO) and thiol (-SH) groups, while the main DNA oxidation Table 3 Logistic regression model with risk factors of PV compared with healthy control groups (age and sex are enrolled as covariates for each variable below).
Variables
Adjusted OR (95% CI product is 8-hydroxy-2-deoxyguanosine. To defend against oxidative damage, the body has an effective antioxidant defence system, which is divided into the enzymatic and nonenzymatic antioxidant systems; the former mainly includes superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px), while the latter mainly includes glutathione (GSH), vitamin C, UA, bilirubin, vitamin E, copper, zinc and selenium. It was reported that patients with PV have an increase in oxidative stress. Naziro glu et al. 15 showed that the activity of enzymatic (CAT, GSH-Px) and nonenzymatic (vitamins A and E) antioxidants was markedly decreased in patients with PV compared with HCs, using increased MDA levels as a lipid peroxidation marker. Yesilova et al. 16 reported that serum TOC and LOOH levels were higher in patients with PV than in HCs, while Yousefi et al. 17 reported that levels of GSHPx, selenium and UA were lower in patients with PV than in HCs. In our study, we found that serum levels of Tbil, Dbil, Ibil, UA and albumin were lower in patients with PV than in HCs. It is noteworthy that in our study, the significant decrease in serum levels of UA in patients with PV was in accordance with the results of Yousefi et al., 17 whereas our results for serum levels of Tbil, Dbil and Ibil, which were also decreased in patients with PV, were not consistent with those results. This might have been due to differences in ethnicity and sample size.
Bilirubin is an endogenous antioxidant with antiinflammatory and immunomodulation effects. Previous studies have reported that lower serum levels of bilirubin are relevant to multiple sclerosis (MS), 18 myasthenia gravis (MG) 19 and the adverse outcomes of severe sepsis. 20 In addition, Zhou et al. 21 showed that bilirubin level may be vital to the inflammatory process in psoriasis, and that lower levels of serum bilirubin are a potential risk factor for patients with PV. The end product of the common pathway of purine metabolism is UA, which is a natural antioxidant, and reduction in UA levels has also been demonstrated to be associated with MG, 19 as well as polymyositis and dermatomyositis. 22 Further, Hooper et al. 23 have shown that UA has therapeutic effects in prevention and delay of initiation and progression of disease activity in an animal model of MS. Serum albumin is a major antioxidant in extracellular fluids, and reduction in its levels has also been demonstrated to be associated with arterial occlusive disease 24 and neuromyelitis optica. 25 There are some important limitations to the present investigation. First, we did not evaluate some antioxidant enzymes (SOD, CAT and GSH-Px) or their correlations with disease severity in our patients. In addition, we did not assess serum levels of bilirubin, UA and albumin in treated patients with PV. Thus, further studies are needed to evaluate the antioxidant status of serumbilirubin, UA and albumin in patients with PV in more detail.
Conclusion
This study showed that patients with PV had low serum bilirubin, UA and albumin levels, indicating low antioxidant status for these proteins. We speculate that the inflammation occurring in PV leads to consumption of bilirubin, UA and albumin during scavenging of excessive free radicals, leading to a consequent reduction in their serum levels. Our data supports the hypothesis that oxidative stress and antioxidant status are important in the pathogenic mechanism of PV. It may of benefit to administer bilirubin, UA and albumin or their precursors as a replacement therapy to patients with PV who have low antioxidant status.
